about
Murine muscle engineered from dermal precursors: an in vitro model for skeletal muscle generation, degeneration, and fatty infiltration.New tacrine-dihydropyridine hybrids that inhibit acetylcholinesterase, calcium entry, and exhibit neuroprotection properties.Old phenothiazine and dibenzothiadiazepine derivatives for tomorrow's neuroprotective therapies against neurodegenerative diseases.The Stimulated Glycolytic Pathway Is Able to Maintain ATP Levels and Kinetic Patterns of Bovine Epididymal Sperm Subjected to Mitochondrial Uncoupling.N-acylaminophenothiazines: neuroprotective agents displaying multifunctional activities for a potential treatment of Alzheimer's disease.An update on the pharmacology of galantamine.Regulation by L-type calcium channels of endocytosis: an overview.Improving treatment adherence in your patients with schizophrenia: the STAY initiative.The neuroprotection exerted by memantine, minocycline and lithium, against neurotoxicity of CSF from patients with amyotrophic lateral sclerosis, is antagonized by riluzole.Benzothiazepine CGP37157 and its isosteric 2'-methyl analogue provide neuroprotection and block cell calcium entryMultipotent drugs with cholinergic and neuroprotective properties for the treatment of Alzheimer and neuronal vascular diseases. I. Synthesis, biological assessment, and molecular modeling of simple and readily available 2-aminopyridine-, and 2-chloSynthesis, inhibitory activity of cholinesterases, and neuroprotective profile of novel 1,8-naphthyridine derivatives.Novel tacrine-8-hydroxyquinoline hybrids as multifunctional agents for the treatment of Alzheimer's disease, with neuroprotective, cholinergic, antioxidant, and copper-complexing properties.Synergistic neuroprotective effect of combined low concentrations of galantamine and melatonin against oxidative stress in SH-SY5Y neuroblastoma cells.Neuroprotective and cholinergic properties of multifunctional glutamic acid derivatives for the treatment of Alzheimer's disease.Tacripyrines, the first tacrine-dihydropyridine hybrids, as multitarget-directed ligands for the treatment of Alzheimer's disease.Tacrine-melatonin hybrids as multifunctional agents for Alzheimer's disease, with cholinergic, antioxidant, and neuroprotective properties.Bcl2 mitigates Ca2+ entry and mitochondrial Ca2+ overload through downregulation of L-type Ca2+ channels in PC12 cells.Chondroitin sulfate protects SH-SY5Y cells from oxidative stress by inducing heme oxygenase-1 via phosphatidylinositol 3-kinase/Akt.Synthesis of 6-amino-1,4-dihydropyridines that prevent calcium overload and neuronal death.Can cholinesterase inhibitors provide additional effects to cholinergic neurotransmission enhancement?Synthesis and biological evaluation of new 4H-pyrano[2,3-b]quinoline derivatives that block acetylcholinesterase and cell calcium signals, and cause neuroprotection against calcium overload and free radicals.Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors.ITH4012 (ethyl 5-amino-6,7,8,9-tetrahydro-2-methyl-4-phenylbenzol[1,8]naphthyridine-3-carboxylate), a novel acetylcholinesterase inhibitor with "calcium promotor" and neuroprotective properties.Galantamine prevents apoptosis induced by beta-amyloid and thapsigargin: involvement of nicotinic acetylcholine receptors.Melatonin-sulforaphane hybrid ITH12674 induces neuroprotection in oxidative stress conditions by a 'drug-prodrug' mechanism of actionDistinct protein kinases regulate SNAP-25 expression in chromaffin cells.Poststress treatment with PNU282987 can rescue SH-SY5Y cells undergoing apoptosis via α7 nicotinic receptors linked to a Jak2/Akt/HO-1 signaling pathway.Mitochondrial Na+/Ca2+ exchanger, a new target for neuroprotection in rat hippocampal slices.Permissive role of sphingosine on calcium-dependent endocytosis in chromaffin cells.Blockade by nanomolar resveratrol of quantal catecholamine release in chromaffin cells.Calcium entry through slow-inactivating L-type calcium channels preferentially triggers endocytosis rather than exocytosis in bovine chromaffin cells.SNX482 selectively blocks P/Q Ca2+ channels and delays the inactivation of Na+ channels of chromaffin cells.Galantamine and memantine produce different degrees of neuroprotection in rat hippocampal slices subjected to oxygen-glucose deprivation.Differences in the vascular selectivity and tolerance between the NO donor/beta-blocker PF9404C and nitroglycerin.Chondroitin sulfate, a major component of the perineuronal net, elicits inward currents, cell depolarization, and calcium transients by acting on AMPA and kainate receptors of hippocampal neurons.Mitochondrial Na+/Ca2+-exchanger blocker CGP37157 protects against chromaffin cell death elicited by veratridine.Inhibition of N and PQ calcium channels by calcium entry through L channels in chromaffin cells.NP04634 prevents cell damage caused by calcium overload and mitochondrial disruption in bovine chromaffin cells.Effects of memantine and galantamine given separately or in association, on memory and hippocampal neuronal loss after transient global cerebral ischemia in gerbils.
P50
Q30560376-C6570296-A77D-47ED-AEA7-315AA1C22976Q33353245-C8FB200C-3D97-4E63-A254-71FBD03CD61BQ33711665-984A0B33-EAE3-4CD1-8694-39C42047078FQ33734118-35217751-2581-439E-B03A-30F1FFDFEBDAQ33850729-A226F610-58C3-4392-972A-9BEAE0AA9BCDQ37016107-DE975B58-3791-4287-8EEC-1812E101E182Q38009744-76255F7A-A4BE-442D-A15F-F98B8361233DQ38071595-D676E0D8-856F-446F-85A6-918F4083E337Q39290825-8C0114A5-F59F-4BB8-A0E0-F96C098176F6Q39302882-58FCAB3A-3016-4244-B475-7BD3D4B1E124Q39676247-3BDF3184-96EC-477B-B532-5A8DA640B1B8Q39688701-7E99B16E-BA19-414C-B662-3768D87873AAQ39693630-0C9FF015-1732-4BBB-AC77-F9C6DFB4F641Q39694999-7467219F-7C94-41CF-ADA1-A7956E67773AQ39783467-7678A207-9523-47B9-93C4-1908BFD7C78DQ39859798-6DAB033B-DEA7-4323-89C8-873A7BD9ED41Q39869084-B74E5529-3BB0-491C-A704-12D2D4C896EBQ40001651-B621565B-8693-4F61-9316-89C26F99BE65Q40077832-963DB161-82D8-44D7-87C1-270851B7000BQ40095365-5075DFA0-638D-49F8-9DB2-54F6B0DAF77CQ40189602-C3D84CEB-EA2B-4DC1-9B72-4ACF9044BE83Q40222165-7C0B7B06-E03E-4E1F-902C-C0942D853E10Q40376638-B0519699-C641-4596-B9A3-58E252BD0DF0Q40562226-5D4C2CFB-5B17-4197-8225-942C319ABBC0Q40610954-EA68F189-A259-4D5E-9037-FD22E2A8AB34Q42107527-3A092E66-C14C-4F4B-9557-C05AA30E28D3Q42435646-E09167E6-EFF8-45CC-9A0C-2A63061A0B27Q42874918-4B2E9090-4DC5-4E0B-B370-DC665FA9D79EQ42936340-266CF248-5FCA-49BB-8BDA-4708B207D561Q42966384-39D93308-5009-44EF-8761-8CEB554E331BQ42970241-CACAB68A-D2DB-41CC-8E2D-4476CC800E5BQ44385427-39A22025-0FBF-423B-A176-CEC1B591F8FEQ44572470-C06C278A-F017-4321-9C16-C04BDE5E806CQ44971808-2593D00C-2E6C-42CF-B196-446F008E9D35Q45056266-4BC6ADA7-6E4D-4B64-B377-DDBA2E032684Q45392051-1FAB0F55-232C-46E7-AF7D-356D31FDF952Q45976080-FF608942-CCCC-44B0-8D6F-670DD0B9852DQ46060719-FEF3CC7F-1D40-4A7E-9461-0F213610F133Q46114392-444F4988-97F3-49BA-9D3A-7E13B699A960Q46186134-FF28F225-6AC2-4ACE-95CA-9CDF21AF3D19
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Antonio G García
@es
Antonio G García
@nl
Antonio G García
@sl
Antonio G. García
@en
type
label
Antonio G García
@es
Antonio G García
@nl
Antonio G García
@sl
Antonio G. García
@en
prefLabel
Antonio G García
@es
Antonio G García
@nl
Antonio G García
@sl
Antonio G. García
@en
P106
P1153
55653270100
P21
P31
P496
0000-0002-6517-3565